Global Isothermal Nucleic Acid Amplification Technology (INAAT) Strategic Business Report 2023: Rising Incidence of Cancer Drives the Sector


Dublin, April 10, 2023 (GLOBE NEWSWIRE) -- The "Isothermal Nucleic Acid Amplification Technology (INAAT): Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering.

The global market for Isothermal Nucleic Acid Amplification Technology (INAAT) estimated at US$2.7 Billion in the year 2022, is projected to reach a revised size of US$6 Billion by 2030, growing at a CAGR of 10.4% over the analysis period 2022-2030.

Reagents, one of the segments analyzed in the report, is projected to record 10.3% CAGR and reach US$4.1 Billion by the end of the analysis period.

Taking into account the ongoing post pandemic recovery, growth in the Instruments segment is readjusted to a revised 10.8% CAGR for the next 8-year period.

The U.S. Market is Estimated at $793.1 Million, While China is Forecast to Grow at 9.8% CAGR

The Isothermal Nucleic Acid Amplification Technology (INAAT) market in the U.S. is estimated at US$793.1 Million in the year 2022. China, the world's second largest economy, is forecast to reach a projected market size of US$1 Billion by the year 2030 trailing a CAGR of 9.8% over the analysis period 2022 to 2030.

Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 9.3% and 8.7% respectively over the 2022-2030 period. Within Europe, Germany is forecast to grow at approximately 8.1% CAGR.

Select Competitors (Total 12 Featured) -

  • Becton, Dickinson and Company
  • bioMerieux SA
  • Eiken Chemical Co., Ltd.
  • Lucigen Corporation
  • Meridian Bioscience, Inc.
  • Nugen Audio
  • QIAGEN GmbH
  • Ustar Biotechnologies (Hangzhou) Ltd.

What`s New for 2023?

  • Special coverage on Russia-Ukraine war; global inflation; easing of zero-Covid policy in China and its `bumpy` reopening; supply chain disruptions, global trade tensions; and risk of recession.
  • Global competitiveness and key competitor percentage market shares
  • Market presence across multiple geographies - Strong/Active/Niche/Trivial
  • Online interactive peer-to-peer collaborative bespoke updates
  • Access to digital archives and Research Platform
  • Complimentary updates for one year

Key Attributes:

Report AttributeDetails
No. of Pages179
Forecast Period2022 - 2030
Estimated Market Value (USD) in 2022$2.7 Billion
Forecasted Market Value (USD) by 2030$6 Billion
Compound Annual Growth Rate10.5%
Regions CoveredGlobal

Key Topics Covered:

I. METHODOLOGY

II. EXECUTIVE SUMMARY

1. MARKET OVERVIEW

  • Influencer Market Insights
  • World Market Trajectories
  • Global Isothermal Nucleic Acid Amplification Technology (INAAT) Market to Witness Healthy Growth, Driven by Low-cost Advantages
  • Isothermal Nucleic Acid Amplification Technology (INAAT) - Global Key Competitors Percentage Market Share in 2022 (E)
  • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2022 (E)
  • Impact of Covid-19 and a Looming Global Recession

2. FOCUS ON SELECT PLAYERS

3. MARKET TRENDS & DRIVERS

  • Rising Incidence of HIV, Hepatitis, and Other Infectious Disease - A Key Factor Propelling the Need for INAAT
  • Global Incidence of HIV by Region: 2017
  • Rising Global Incidence of Cancer Drives the INAAT Market
  • Development of New Technologies to Propel Market Expansion
  • Microfluidic Lab-on-a-chip Technology Aids in Expanding NAAT Use to POCT
  • Global Hepatitis B Incidence and Mortality Rates

4. GLOBAL MARKET PERSPECTIVE

III. MARKET ANALYSIS

IV. COMPETITION

For more information about this report visit https://www.researchandmarkets.com/r/crhn6r

About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

Attachment

 
Global Market for Isothermal Nucleic Acid Amplification Technology (INAAT)

Contact Data